931 related articles for article (PubMed ID: 17198350)
21. New bone-seeking agent: animal study of Tc-99m-incadronate.
Shigematsu M; Shomi S; Iwao H; Ochi H
Ann Nucl Med; 2002 Feb; 16(1):55-9. PubMed ID: 11922209
[TBL] [Abstract][Full Text] [Related]
22. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
[TBL] [Abstract][Full Text] [Related]
23. 99mTc(CO)3-labeled pamidronate and alendronate for bone imaging.
Palma E; Correia JD; Oliveira BL; Gano L; Santos IC; Santos I
Dalton Trans; 2011 Mar; 40(12):2787-96. PubMed ID: 21301703
[TBL] [Abstract][Full Text] [Related]
24. Binding of technetium-99m to plasma proteins: influence on the distribution of Tc-99m phosphate agents.
Schümichen C; Koch K; Kraus A; Kuhlicke G; Weiler K; Wenn A; Hoffman G
J Nucl Med; 1980 Nov; 21(11):1080-5. PubMed ID: 7431108
[TBL] [Abstract][Full Text] [Related]
25. Chemical and biological evaluation of technetium (I) tricarbonyl complexes with EHIDA and DPD. 99m (I) complexes of EHIDA and DPD.
Djokić DDj; Janković DLj; Stamenković LLj; Pirmettis I
Nucl Med Rev Cent East Eur; 2004; 7(1):1-5. PubMed ID: 15318303
[TBL] [Abstract][Full Text] [Related]
26. Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis.
Fonge H; Chitneni SK; Lixin J; Vunckx K; Prinsen K; Nuyts J; Mortelmans L; Bormans G; Ni Y; Verbruggen A
Bioconjug Chem; 2007; 18(6):1924-34. PubMed ID: 17929883
[TBL] [Abstract][Full Text] [Related]
27. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
28. Antecedent 99mTc-MDP and 99mTc-sestamibi administration corrupts bone mineral density measured by DXA.
McKiernan FE; Hocking J; Cournoyer S
J Clin Densitom; 2006; 9(2):164-6. PubMed ID: 16785076
[TBL] [Abstract][Full Text] [Related]
29. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2008 Mar; 49(3):375-82. PubMed ID: 18287266
[TBL] [Abstract][Full Text] [Related]
30. External and biopsy determination of preoperative Tc-99m MDP femoral-head labeling in fracture of the femoral neck: concise communication.
Strömqvist B; Brismar J; Hansson LI; Thorngren KG
J Nucl Med; 1984 Aug; 25(8):854-8. PubMed ID: 6235328
[TBL] [Abstract][Full Text] [Related]
31. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y
Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
[TBL] [Abstract][Full Text] [Related]
32. [99m-Tc alendronate as a new option in bone gammagraphy].
Montoya-Molina CE; Sepúlveda-Méndez J; Arteaga-de-Murphy C; Meléndez-Alafort L; Rojas-Bautista JC; López-Alvarenga JC
Rev Invest Clin; 1997; 49(5):373-7. PubMed ID: 9527697
[TBL] [Abstract][Full Text] [Related]
33. [Regional blood flow and bone uptake of methylene-diphosphonate-technetium-99m].
Vattimo A; Martini G; Pisani M
Boll Soc Ital Biol Sper; 1983 May; 59(5):590-5. PubMed ID: 6192828
[TBL] [Abstract][Full Text] [Related]
34. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
Wang TS; Fawwaz RA; Johnson LJ; Mojdehi GE; Johnson PM
J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
[TBL] [Abstract][Full Text] [Related]
35. Determination of lesion to normal bone uptake ratios of skeletal radiopharmaceuticals by QARG (quantitative autoradiography).
Ghiron J; Volkert WA; Garlich J; Holmes RA
Int J Rad Appl Instrum B; 1991; 18(2):235-40. PubMed ID: 2026500
[TBL] [Abstract][Full Text] [Related]
36. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
Ergün EL; Kiratli PO; Günay EC; Erbaş B
Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428
[TBL] [Abstract][Full Text] [Related]
37. The effect of MRI contrast agents on hepatic and splenic uptake in the rabbit during (99m) Tc-MDP bone scintigraphy.
Qiu L; Tang Y; Chen Y; Huang Z; Zhu Y; Zhang L; Cai L; Wan Q; Feng Y
Contrast Media Mol Imaging; 2015; 10(6):438-45. PubMed ID: 26036779
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of (99m)Tc-DMP-NGA as a novel hepatic asialoglycoprotein receptor imaging agent.
Yang W; Mou T; Zhang X; Wang X
Appl Radiat Isot; 2010 Jan; 68(1):105-9. PubMed ID: 19815422
[TBL] [Abstract][Full Text] [Related]
39. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of novel cationic 99mTc(I)-tricarbonyl complexes as potential radiotracers for myocardial perfusion imaging.
He Z; Hsieh WY; Kim YS; Liu S
Nucl Med Biol; 2006 Nov; 33(8):1045-53. PubMed ID: 17127179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]